Allogene Therapeutics Inc - ALLO - stock price prediction, stock price target, analyst ratings from 16 analysts
Allogene Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of -50.0%, and profit growth estimate of 1.5% for FY25, based on top 16 analyst calls.